Effects of Hot Baths Prior or After a Damaging Protocol on Muscle Function and HSP70 Expression (Prehotemp)

April 23, 2026 updated by: Centre Hospitalier Universitaire, Amiens

Muscle lengthening contractions lead to physiological responses such as strength loss, soreness, immune cell infiltration, and CK production, along with elevated heat shock proteins (HSPs), which protect and regenerate cells. Passive heating before or after exercise can aid in recovery by restoring strength and reducing soreness, requiring a core temperature of over 38.5°C for 20 minutes to be effective. Studies show that combined mechanical and thermal stress induces a cumulative HSP response, enhancing cellular protection. Thermal stress alone peaks at 16- 24 hours, whereas mechanical stress shows a biphasic response, with peaks at 3-6 hours and around 39 hours. Thus, combining heat with exercise could optimize HSP production, improving recovery by increasing and accelerating the HSP response. However, more research is needed to determine the best timing for thermal stress in human applications, especially in sports and therapy contexts.

This study aimed to compare the effects of hot-water immersion administered before versus after muscle-lengthening exercise on muscle function and HSP70 expression in healthy young athletes.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

96

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Sex: Healthy, athletic men practicing track and field (10 to 12 hours/week)
  • Age: 19 to 25 years old
  • Social security coverage
  • Signed informed consent

Exclusion Criteria:

  • Age over 26 years
  • Low level of physical activity (less than 8 hours per week)
  • Recent sprain (type 1, 2, or 3) or ligament rupture in the lower limb (within the last 8 months)
  • Exposure to an altitude of 2500m within 15 days prior to the protocol
  • Presence of arterial hypotension:
  • Systolic blood pressure below 90 mmHg
  • Diastolic blood pressure below 60 mmHg
  • A drop in systolic blood pressure greater than 20 mmHg upon moving from a lying to a standing position.
  • A drop in diastolic blood pressure greater than 10 mmHg upon moving from a lying to a standing position.
  • Presence of dizziness, lightheadedness, or blurred vision upon moving from a lying to a standing position.
  • Participant under guardianship/conservatorship or deprived of liberty.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: 41 pre-EIMD
hot-water immersion at 41°C performed 24 hours before EIMD (pre-EIMD)
Immersion lasted 40 minutes with the goal of reaching a core temperature of 38.5°C in the heat-stress groups
NIRS
isokinetic dynamometer
pressure algometer
Hokanson armband
Experimental: 41 post-EIMD
hot- water immersion at 41°C immediately after EIMD (post-EIMD)
Immersion lasted 40 minutes with the goal of reaching a core temperature of 38.5°C in the heat-stress groups
NIRS
isokinetic dynamometer
pressure algometer
Hokanson armband
Sham Comparator: 36°C post- EIMD
sham immersion at 36°C post- EIMD
Immersion lasted 40 minutes with the goal of reaching a core temperature of 38.5°C in the heat-stress groups
NIRS
isokinetic dynamometer
pressure algometer
Hokanson armband

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
HSP 70 concentration
Time Frame: 1 year
HSP 70 concentration in third groups
1 year

Secondary Outcome Measures

Outcome Measure
Time Frame
gastro-intestinal temperature
Time Frame: 1 year
1 year
muscle temperature
Time Frame: 1 year
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 16, 2026

Primary Completion (Estimated)

February 1, 2027

Study Completion (Estimated)

February 1, 2027

Study Registration Dates

First Submitted

April 7, 2026

First Submitted That Met QC Criteria

April 23, 2026

First Posted (Actual)

April 30, 2026

Study Record Updates

Last Update Posted (Actual)

April 30, 2026

Last Update Submitted That Met QC Criteria

April 23, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Recovery

Clinical Trials on Immersion

Subscribe